Hapana chirwere chinogona kutora autism zvakananga, asi vazhinji vanogona kubatsira nezviratidzo zvayo
Wakaverenga kuti hakuna chirwere chinorapa chichirapa che autism , asi chiremba wako ari kurondedzera mishonga. Chii ichocho pamusoro? Mhinduro yacho iri nyore. Chiremba wako haasi kurapa autism: iye kana ari kuratidza zviratidzo zvakananga zve autism. Kakawanda, apo zviratidzo zvinotapurirwa, vanhu vane autism vanogona kukwanisa kudzidza, kukurukurirana, uye kazhinji kubatana nevamwe.
Zviratidzo zveViismism Zvinogona Kutariswa Nezvinodhaka
Haasi munhu wose ane autism spectrum disorder ane zviratidzo zvakafanana, uye kwete zviratidzo zvose zvinogona kurapwa nemishonga. Kazhinji kacho, kana zvinodhaka zvinorayirirwa kune vanhu vane autism, zvinotarisirwa kugadzirisa zviratidzo zvinosanganisira nyaya dzekuita, kuzvidya mwoyo, kuora mwoyo, kusagadzikana-kusagadzikana kwepfungwa, nyaya dzekutarisa, kusagadzikana, uye mafungiro anokanganisa kubva kune zvakadai se bipolar disorder.
Kubata Kuzvidya Mwoyo uye Kuora Mwoyo
Kusarura serotonin reuptake inhibitors (SSRIs) inorayirwa kuve nekuzvidya mwoyo, kuora mwoyo, uye / kana kukanganisa-kusagadzikana kwepfungwa (OCD). Pakati peizvi, Prozac chete (fluoxetine) yakagamuchirwa neDain and Drug Administration (FDA) yezvose zvinodzvinyirira mune vana vane makore 8 nekure uye OCD muvana vanomwe kana kupfuura. Lexapro (escitalopram) inobvumirwawo kuvana vane kuora mwoyo vane makore 12 kana kupfuura. Nhatu SSRIs dzakabvumirwa OCD ndeye Luvox (fluvoxamine) yevana vane makore 8 nekure; Zoloft (sertraline) yevana vane makore matanhatu nekure; uye Anafranil (clomipramine) yevana vane makore gumi nevekare.
Wellbutrin is antidipressant iyo inoshanda zvakasiyana nedzimwe sangano re SSRI revanodzvinyirira uye harina kubvumirwa kushandiswa kwevana.
Dhiyabhorosi yeDAA Pamusoro peSRIRI Zvinodhaka
Iyo FDA yakabudisa mazano kuvarwere, mhuri, uye vashandi vehutano kunyatsotarisa vanhu vakuru nevana vanotora zvirwere zvinoderedza zviratidzo zvekuzviuraya.
Izvi zvinonyanya kukosha pakutanga kwekurapa kana kana mazamu akachinjwa.
Kurapa Zvinetso Zvokuita
Vazhinji vevana vane mavhisi vane matambudziko makuru ekuzvibata. Zvimwe zvinogona kutarisirwa nemishonga isiri yemishonga yakadai sekushandisa maitiro ekuongorora (ABA), Floortime therapy, nezvimwewo. Asi kana maitiro asingakwanisi kudzora kana kuti ane ngozi, inogona kuva nguva yekufunga nezvemishonga inopesana nemapiritsi. Izvi zvinoshanda nekuderedza basa rerourotransmitter dopamine muuropi. Kune marudzi maviri e-antipsychotics, kusanganisira:
- Makwegura ekurapa-antipyrotic: Mishonga yakwegura yekurapa inoshandiswa sehaloperidol, thioridazine, fluphenazine, uye chlorpromazine, inogona kushanda mukurapa zvinetso zvakakomba. Asi zvose, kusanganisira haloperidol, inogona kuva nemigumisiro yakakomba yakadai sedation, kusuruvara kwemitsipa, uye kufamba kusina kujairika, saka mishonga iyi inoshandiswa chete kana itsva antipsychotics isingaiti basa.
- Mishonga mitsva yekurapa-antipychotic: Zvimwe zvezvino "atypical" antipsychotics zvinogona kuva sarudzo yakanaka, zvikurukuru yevana. Imwe yongororo yapfuura yakaratidza kuti Risperdal (risperidone) uye Abilify (aripiprazole) vakashanda zvakanaka kuti vabatsire kudzora utsinye nekutsamwa kwevana. Zvose izvi FDA-inogamuchirwa kutarisa kushungurudzwa kwevana vane autism; Risperdal inobvumirwa kune vana vashanu kana kupfuura uye Abilify inogamuchirwa kuvana 6 nekukwira.
Kurapa Matambudziko
Mumwe muvanhu vana vane autism spectrum disorder (ASD) ane chirwere chekubata. Kazhinji, vanobatwa neanticonvulsants vakaita seTegretol (carbamazepine), Lamictal (lamotrigine), Topamax (topiramate), kana Depakote (valproic acid). Nhamba yemishonga iri muropa inofanira kuongororwa zvakanyatsogadziriswa uye kugadziriswa kuitira kuti zvishoma zvacho zvigone kushandiswa zvinoshandiswa kuti zvibudirire. Kunyange zvazvo mishonga inowanzoderedza nhamba yekubatwa, haigoni kuibvisa zvachose.
Kurapa Inatten uye Hyperactivity
Zvinokurudzira mishonga yakadai seConta (methylphenidate) uye Strattera (atomoxetine) yakashandiswa zvakachengeteka uye zvinobudirira kune vanhu vane hanya-kukanganisa kusagadzikana kwehutano (ADHD) zvakare vakagadzirirwa vana vane autism.
Iyi mishonga inogona kuderedza kusagadzikana uye kusagadzikana mune vamwe vana, zvikuru avo vane vana vanoshanda zvakakwirira. Adderall (dextroamphetamine uye amphetamine) chimwe chinokurudzira chinowanzoshandiswa nenzira imwecheteyo seConta kana Strattera kuti ibatsire nekucherechedza, kuisa pfungwa, uye maitiro ehutano. Clorpres (clonidine), ine antihypertensive, dzimwe nguva inorondedzerwa yekusagadzikana uye kusagadzikana zvakare.
Kuongorora Mishonga Yezvinodhaka
Mishonga yose inotsanangurwa munyaya ino ine mikana yemigumisiro. Zvimwe, kana zvakatemerwa kuti zvive zvevistism, zvinorayirwa kuti "off-label," zvinoreva kuti ivo vakanyorerwa kune zvimwe zvinopfuura izvo zvavakabvumirwa. Ingoyeuka kuti hapana kupindira kwemishonga inouya pasina njodzi.
Tsvaga Nechiremba
Nemhaka yehutano hwekupindira kwemishonga chero ipi zvayo, zvinonzwisisika kushandiswa zvinodhaka chete kana uye kana zviratidzo zvakanyanya kana kusingadzorwiki nedzimwe nzira. Kunyangwe zvakadaro, zvakakosha zvikuru kuti iwe uone chiremba wezvechiremba ane ruzivo mu autism uye, kana zvakakodzera, pediatrics. Iva nechokwadi chokuti iwe unonzwisisa zvinogona kuitika. Bvunza chiremba wako kana chimwe chezvikamu izvi zvinokonzera zvinogona kuva nengozi uye iva nechokwadi chekuti unoziva chii chaunofanira kuita kana pane matambudziko akamuka. Ita sangano rekutsvaga kuitira kuti chiremba wako anokwanisa kuongorora kubudirira kwehutano uye kurudzira chero kuchinja kune kuyerwa.
> Sources:
> DeFilippis M, Wagner KD. Kurapa kweAvism Spectrum Disorder muvana nevana vaduku. Psychopharmacology Bulletin . 2016; 46 (2): 18-41.
> Mayo Clinic Staff. Anodzvinyirira vana nevechiri kuyaruka. Mayo Clinic. Yakapedzwa musi waMay 27, 2016.
> Van Schalkwyk GI, Lewis AS, Beyer C, Johnson J, van Rensburg S, Bloch MH. Kubudirira kweAntipsychotics yeKutsamwisa uye Kurwisana muvana: Meta-Analysis. Ongororo Ongororo yeNeurotherapeutics . September 11, 2017; 17 (10): 1045-1053. doi: 10.1080 / 14737175.2017.1371012.